CARCINOMA of the palatine tonsil is the second most common malignancy of the oropharynx. Early lesions have an excellent chance for cure but offer difficulty in diagnosis. The majority develop insidiously and present as advanced disease, both locally and by cervical adenopathy.
Carcinoma originating in the tonsillar fossa can easily spread to the anterior and posterior pillars, pharyngeal wall, soft palate, tongue, gingiva, and mandible. Because of the rich lymphatic supply of the region, lymph node metastases are a common presenting sign.1
Until recently, irradiation and surgery have had little to offer in the advanced cases. A high percentage of postoperative complications followed the required ultraradical resection. Radiotherapy, without the general availability of supervoltage or telecobalt, encountered difficulties in delivering a tumorcidal dose to the required large volume without damage to the normal surrounding bone and soft tissue.
In recent years there has been a renaissance of the surgical
Brizel HE, Scott RM. Cobalt 60 Irradiation for Advanced Carcinoma of the Palatine Tonsil. JAMA. 1965;192(8):723–725. doi:10.1001/jama.1965.03080210067026
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: